Potentially Macrocyclic Peptidyl Boronic Acids as Chymotrypsin Inhibitors

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Enzyme Inhibitor Design

Background:

• Serine proteases are crucial enzymes involved in various physiological processes.
• Understanding enzyme inhibition mechanisms is key to developing targeted therapeutics.
• Peptide boronate adducts offer a promising strategy for mimicking enzyme transition states.

Purpose of the Study:

• To investigate the formation of peptide boronate adducts in serine protease active sites.
• To design and synthesize complex boronic acid analogs that mimic tetrahedral intermediates.
• To evaluate the inhibitory potential of these analogs against alpha-chymotrypsin.

Main Methods:

• Synthesis of complex peptidyl boronates using protected amino acid derivatives and borophenylalanine.
• Development of stereoselective synthetic routes for key intermediates.
• Enzyme inhibition assays to determine the inhibitory constants (Ki) of the synthesized compounds.

Main Results:

• Peptidyl boronates 7 and 8-OH demonstrated potent inhibition of alpha-chymotrypsin with Ki values of 26 nM and 68 nM, respectively.
• Inhibitor 7 exhibited time- and pH-independent binding, suggesting a stable adduct formation.
• The affinity of the cyclizable inhibitors was significantly greater than non-cyclizable analogs.

Conclusions:

• Complex peptide boronates can effectively mimic tetrahedral intermediates in serine protease mechanisms.
• These compounds represent potent and potentially stable inhibitors of alpha-chymotrypsin.
• The macrocyclization strategy enhances inhibitor affinity and stability, offering a promising avenue for drug development.